General Electric (GE) PT Raised To $13 At Barclays After BioPharma Divestiture
Tweet Send to a Friend
Barclays analyst, Julian Mitchell, reiterated his Overweight rating on shares of General Electric (NYSE: GE) and raised his price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


